Recombinant Mouse Il25 Protein, MYC/DDK-tagged
| Cat.No. : | Il25-1011M |
| Product Overview : | Purified recombinant protein of full-length mouse interleukin 25 (Il25), with C-terminal MYC/DDK tag, was expressed in HEK293T cells. |
- Specification
- Gene Information
- Related Products
| Description : | Low expression observed in reference dataset. |
| Source : | HEK293T |
| Species : | Mouse |
| Tag : | MYC/DDK |
| Molecular Mass : | 19.2 kDa |
| Purity : | >80% as determined by SDS-PAGE and Coomassie blue staining |
| Stability : | Stable for 12 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles. |
| Storage : | Store at -80 centigrade after receiving vials. |
| Concentration : | >50 µg/mL as determined by microplate BCA method |
| Storage Buffer : | 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10% glycerol. |
| Gene Name : | Il25 interleukin 25 [ Mus musculus (house mouse) ] |
| Official Symbol : | Il25 |
| Synonyms : | Il25; interleukin 25; Il17e; IL-17e; interleukin-25; interleukin 17E |
| Gene ID : | 140806 |
| mRNA Refseq : | NM_080729 |
| Protein Refseq : | NP_542767 |
| UniProt ID : | Q8VHH8 |
Products Types
| ◆ Recombinant Protein | ||
| Il25-183M | Recombinant Active Mouse IL25 Protein, His-tagged(C-ter) | +Inquiry |
| IL25-165H | Recombinant Human IL25 Protein | +Inquiry |
| IL25-166M | Recombinant Mouse IL25 Protein | +Inquiry |
| IL25-1926H | Recombinant Human IL25 Protein, MYC/DDK-tagged | +Inquiry |
| IL25-1924M | Recombinant Mouse IL25 Protein | +Inquiry |
| ◆ Lysates | ||
| IL25-2910MCL | Recombinant Mouse IL25 cell lysate | +Inquiry |
| IL25-1261RCL | Recombinant Rat IL25 cell lysate | +Inquiry |
| IL25-2920HCL | Recombinant Human IL25 cell lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (6)
Ask a questionThere is a lack of conclusive evidence that IL-25 has a clear effect in tumor treatment, but there are some studies underway.
There are no clear studies on the side effects of IL-25, but the patient response needs to be closely monitored during research and clinical application.
In addition to treating asthma and inflammatory bowel disease, IL-25 may also have potential applications in the treatment of lung infections, urticaria and other diseases.
IL-25 activates specific signaling pathways by binding to specific receptors, thereby regulating the activity of immune cells and the degree of inflammation in the body.
Some studies have shown that recombinant IL-25 can improve symptoms of diseases such as asthma and inflammatory bowel disease, but more research is needed to verify its efficacy.
Yes, in general, IL-25 therapy needs to be administered by injection to ensure that the protein can enter the body and work.
Customer Reviews (3)
Write a reviewEfficacy of the protein can be evaluated by observing its pharmacokinetics, pharmacodynamics and toxicity in mice or rats. -
Animal models were used to evaluate the efficacy and side effects of the remade proteins. -
Storage is stable, and the environmental requirements are not harsh. -
Ask a Question for All Il25 Products
Required fields are marked with *
My Review for All Il25 Products
Required fields are marked with *
Inquiry Basket
